Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

BERLIN, May 05, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

Teva Pharmaceutical Industries reported a larger than expected rise in first-quarter profit, helped by strong sales gains for ...

After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other outfits across the life sciences spectrum are ...

WEST CONSHOHOCKEN – Medicus Pharma Ltd. has agreed to acquire Antev Ltd., a British late clinical-stage drug development company. The two companies recently entered into a binding letter of ...

HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump administration. This time it’s Gilead coming to the table with a ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

President Donald Trump signaled that he plans to announce new tariffs on pharmaceutical products imported to the United States “over the next two weeks.” Trump’s overriding tariff agenda has ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...